Prosthetic joint infections: microbiology, diagnosis, management and prevention

International Journal of Antimicrobial Agents

Volumn 32, Issue 4, 2008, Pages 287-293

  Esposito, Silvano ^a   Leone, Sebastiano ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b S G MOSCATI HOSPITAL   (Italy)

Author keywords

Antimicrobial treatment; Biofilm; Infectious diseases specialist; Outpatient parenteral antimicrobial therapy; Prosthetic joint infections

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFAZOLIN; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALBAVANCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; FLUORODEOXYGLUCOSE; FROPENEM; FUSIDIC ACID; GALLIUM 67; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; LEVOFLOXACIN; LINEZOLID; MEDRONATE TECHNETIUM TC 99M; MINOCYCLINE; ORITAVANCIN; PLACEBO; POLYPEPTIDE ANTIBIOTIC AGENT; RIFAMPICIN; TEICOPLANIN; TELAVANCIN; TIGECYCLINE; UNINDEXED DRUG; VANCOMYCIN;

ANEMIA; ANTIBIOTIC PROPHYLAXIS; ANTIMICROBIAL THERAPY; BIOFILM; BLOOD ANALYSIS; BONE SCINTISCANNING; CHRONIC OSTEOMYELITIS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG WITHDRAWAL; HISTOPATHOLOGY; HUMAN; INFECTIOUS ARTHRITIS; JOINT PROSTHESIS; LABORATORY DIAGNOSIS; MICROBIAL COLONIZATION; MICROBIOLOGICAL EXAMINATION; MONOTHERAPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTHESIS INFECTION; REIMPLANTATION; SHORT SURVEY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; THROMBOCYTOPENIA; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BIOFILMS; HUMANS; JOINT PROSTHESIS; PROSTHESIS-RELATED INFECTIONS;

EID: 50549104733     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.03.010     Document Type: Short Survey

References (74)

1. Masterson E.L., Masri B.A., and Duncan C.P. Treatment of infection at the site of total hip replacement. Instr Course Lect 47 (1998) 297-306
2. Sculco T.P. The economic impact of infected total joint arthroplasty. Instr Course Lect 42 (1993) 349-351
3. Lentino J.R. Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists. Clin Infect Dis 36 (2003) 1157-1161
4. Zimmerli W. Infection and musculoskeletal conditions: prosthetic-joint-associated infections. Best Pract Res Clin Rheumatol 20 (2006) 1045-1063
5. Sculco T.P. The economic impact of infected joint arthroplasty. Orthopedics 18 (1995) 871-873
6. Fisman D.N., Reilly D.T., Karchmer A.W., and Goldie S.J. Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly. Clin Infect Dis 32 (2001) 419-430
7. Berbari E.F., Hanssen A.D., Duffy M.C., Steckelberg J.M., Ilstrup D.M., Hrmsen W.S., et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 27 (1998) 1247-1254
8. Hoekman P., van de Perre P., Nelissen J., Kwisanga B., Bogaerts J., and Kanyangabo F. Increased frequency of infection after open reduction of fractures in patients who are seropositive for human immunodeficiency virus. J Bone Joint Surg Am 73 (1991) 675-679
9. Zimmerli W., Trampuz A., and Ochsner P.E. Prosthetic-joint infections. N Engl J Med 351 (2004) 1645-1654
10. Trampuz A., and Widmer A.F. Infections associated with orthopedic implants. Curr Opin Infect Dis 19 (2006) 349-356
11. Sia I.G., Berbari E.F., and Karchmer A.W. Prosthetic joint infections. Infect Dis Clin North Am 19 (2005) 885-914
12. Barberan J. Management of infections of osteoarticular prosthesis. Clin Microbiol Infect 12 (2006) 93-101
13. Weil Y., Mattan Y., Liebergall M., and Rahav G. Brucella prosthetic joint infection: a report of 3 cases and a review of the literature. Clin Infect Dis 36 (2003) 81-86
14. Marculescu C.E., Berbari E.F., Cockerill 3rd F.R., and Osmon D.R. Fungi, mycobacteria, zoonotic and other organisms in prosthetic joint infection. Clin Orthop Relat Res 451 (2006) 64-72
15. Sendi P., Rohrbach M., Graber P., Frei R., Ochsner P.E., and Zimmerli W. Staphylococcus aureus small colony variants in prosthetic joint infection. Clin Infect Dis 43 (2006) 961-967
16. Berbari E.F., Marculescu C., Sia I., Lahr B.D., Anssen A.D., Steckelberg J.M., et al. Culture-negative prosthetic joint infection. Clin Infect Dis 45 (2007) 1113-1119
17. Talsma S.S. Biofilms on medical devices. Home Healthc Nurse 25 (2007) 589-594
18. Donlan R.M. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 33 (2001) 1387-1392
19. Patel R. Biofilms and antimicrobial resistance. Clin Orthop Relat Res 437 (2005) 41-47
20. Widmer A.F. New developments in diagnosis and treatment of infection in orthopedic implants. Clin Infect Dis 33 (2001) 94-106
21. Virolainen P., Lähteenmaki H., Hiltunen A., Sipola E., Meurman O., and Nelimarkka O. The reliability of diagnosis of infection during revision arthroplasties. Scand J Surg 91 (2002) 178-181
22. Bernard L., Lübbeke A., Stern R., Bru I.P., Feron J.M., Peyramond D., et al. Value of preoperative investigations in diagnosing prosthetic joint infection: retrospective cohort study and literature review. Scand J Infect Dis 36 (2004) 410-416
23. Sanzen L., and Carlsson A.S. The diagnostic value of C-reactive protein in infected total hip arthroplasties. J Bone Joint Surg Br 71 (1989) 638-641
24. Shih L.Y., Wu J.J., and Yang D.J. Erythrocyte sedimentation rate and C-reactive protein values in patients with total hip arthroplasty. Clin Orthop Relat Res 225 (1987) 238-246
25. Bottner F., Wegner A., Winkelmann W., Becker K., Erren M., and Gotze C. Interleukin-6, procalcitonin and TNF-alpha: markers of peri-prosthetic infection following total joint replacement. J Bone Joint Surg Br 89 (2007) 94-99
26. Trampuz A., Hanssen A.D., Osmon D.R., Mandrekar J., Steckelberg J.M., and Patel R. Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am J Med 117 (2004) 556-562
27. Trampuz A., Hanssen A.D., Osmon D.R., Mandrekar J., Steckelberg J.M., and Patel R. Advances in the laboratory diagnosis of prosthetic joint infection. Rev Med Microbiol 14 (2003) 1-14
28. Lonner J.H., Desai P., Dicesare P.E., Steiner G., and Zuckerman I.D. The reliability of analysis of intraoperative frozen sections for identifying active infection during revision hip or knee arthroplasty. J Bone Joint Surg Am 78 (1996) 1553-1558
29. Baré J., MacDonald S.J., and Bourne R.B. Preoperative evaluations in revision total knee arthroplasty. Clin Orthop Relat Res 446 (2006) 40-44
30. Spangehl M.J., Masri B.A., O'Connell J.X., and Duncan C.P. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg Am 81 (1999) 672-683
31. Atkins B.L., Athanasou N., Deeks J.J., Crook D.W., Simpson H., Peto T.E., et al., The OSIRIS Collaborative Study Group. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. J Clin Microbiol 36 (1998) 2932-2939
32. Trampuz A., Piper K.E., Jacobson M.J., Hanssen A.D., Unni K.K., Osmon D.R., et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 357 (2007) 654-663
33. Cuckler J.M., Star A.M., Alavi A., and Noto R.B. Diagnosis and management of the infected total joint arthroplasty. Orthop Clin North Am 22 (1991) 523-530
34. Tigges S., Stiles R.G., and Roberson J.R. Appearance of septic hip prostheses on plain radiographs. AJR Am J Roentgenol 163 (1994) 377-380
35. Goergen T.G., Dalinka M.K., Alazraki N., Berquist T.H., Daffner R.H., DeSmet A.A., et al. Evaluation of the patient with painful hip or knee arthroplasty American College of Radiology. ACR Appropriateness Criteria. Radiology 215 (2000) 295-298
36. Smith S.L., Wastie M.L., and Forster I. Radionuclide bone scintigraphy in the detection of significant complications after total knee joint replacement. Clin Radiol 56 (2001) 221-224
37. Love C., Tomas M.B., Marwin S.E., Pugliese P.V., and Palestro C.J. Role of nuclear medicine in diagnosis of the infected joint replacement. Radiographics 21 (2001) 1229-1238
38. de Winter F., van de Wiele C., Vogelaers D., de Smet K., Verdonk R., and Dierckx R.A. Fluorine-18 fluorodeoxyglucose-position emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am 83 (2001) 651-660
39. Anguita-Alonso P., Hanssen A.D., and Patel R. Prosthetic joint infection. Expert Rev Anti Infect Ther 3 (2005) 797-804
40. Zimmerli W., Widmer A.F., Blatter M., Frei R., Ochsner P.E., and Foreign-Body Infection (FBI) Study Group. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. JAMA 279 (1998) 1537-1541
41. Drancourt M., Stein A., Argenson J.N., Zannier A., Curvale G., and Raoult D. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob Agents Chemother 37 (1993) 1214-1218
42. Berdal J.E., Skramm I., Mowinckel P., Gulbrandsen P., and Bjørnholt J.V. Use of rifampicin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections. Clin Microbiol Infect 11 (2005) 843-845
43. Stengel D., Bauwens K., Sehouli J., Ekkernkamp A., and Porzsolt F. Systematic review and meta-analysis of antibiotic therapy for bone and joint infections. Lancet Infect Dis 1 (2001) 175-188
44. Barberan J., Aguilar L., Carroquino G., Gimenez M.J., Sanchez B., Martinez D., et al. Conservative treatment of staphylococcal prosthetic joint infections in elderly patients. Am J Med 119 (2006) 993-994
45. Drancourt M., Stein A., Argenson J.N., Roiron R., Groulier P., and Raoult D. Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin. J Antimicrob Chemother 39 (1997) 235-240
46. Stein A., Bataille J.F., Drancourt M., et al. Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopaedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob Agents Chemother 42 (1998) 3086-3091
47. Trampuz A., and Zimmerli W. New strategies for the treatment of infections associated with prosthetic joints. Curr Opin Investig Drugs 6 (2005) 185-190
48. Salgado C.D., Dash S., Cantey J.R., and Marculescu C.E. Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. Clin Orthop Relat Res 461 (2007) 48-53
49. Esposito S., Leone S., Noviello S., Ianniello F., Fiore M., Russo M., et al. Outpatient parenteral antibiotic therapy for bone and joint infections: an Italian multicenter study. J Chemother 19 (2007) 417-422
50. Bernard L., El-Hajj, Pron B., Gleizes V., Signoret F., Denormandie P., et al. Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost. J Clin Pharm Ther 26 (2001) 445-451
51. Drew R.H., Perfect J.R., Srinath L., Kurkimilis E., Dowzicky M., Talbot G.H., and For the Synercid Emergency-Use Study Group. Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. J Antimicrob Chemother 46 (2000) 775-784
52. Rana B., Butcher I., Grigoris P., Murnaghan C., Seaton R.A., and Tobin C.M. Linezolid penetration into osteo-articular tissues. J Antimicrob Chemother 50 (2002) 747-750
53. Kutscha-Lissberg F., Hebler U., Muhr G., and Köller M. Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci. Antimicrob Agents Chemother 47 (2003) 3964-3966
54. Bassetti M., Vitale F., Melica G., Righi E., Di Biagio A., Molfetta L., et al. Linezolid in the treatment of Gram-positive prosthetic joint infections. J Antimicrob Chemother 55 (2005) 387-390
55. Razonable R.R., Osmon D.R., and Steckelberg J.M. Linezolid therapy for orthopedic infections. Mayo Clin Proc 79 (2004) 1137-1144
56. Rao N., Ziran B.H., Hall R.A., and Santa E.R. Successful treatment of chronic bone and joint infections with oral linezolid. Clin Orthop Relat Res 427 (2004) 67-71
57. Carpenter C.F., and Chambers H.F. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin Infect Dis 38 (2004) 994-1000
58. Falagas M.E., Giannopoulou K.P., Ntziora F., and Papagelopoulos P.J. Daptomycin for treatment of patients with bone and joint infections: a systematic review of the clinical evidence. Int J Antimicrob Agents 30 (2007) 202-209
59. Stein G.E., and Craig W.A. Tigecycline: a critical analysis. Clin Infect Dis 43 (2006) 518-524
60. Yin L.Y., Lazzarini L., Li F., Stevens C.M., and Calhoun J.H. Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model. J Antimicrob Chemother 55 (2005) 995-1002
61. Bernard L., Hoffmeyer P., Assal M., Vaudaux P., Schrenzel J., and Lew D. Trends in the treatment of orthopaedic prosthetic infections. J Antimicrob Chemother 53 (2004) 127-129
62. Ure K.J., Amstutz H.C., Nasser S., and Schmalzried T.P. Direct-exchange arthroplasty for the treatment of infection after total hip replacement. An average ten-year follow-up. J Bone Joint Surg Am 80 (1998) 961-968
63. Raut V.V., Orth M.S., Orth M.C., Siney P.D., and Wroblewski B.M. One stage revision arthroplasty of the hip for deep gram-negative infection. Int Orthop 20 (1996) 12-14
64. Miley G.B., Scheller Jr. A.D., and Turner R.H. Medical and surgical treatment of the septic hip with one-stage revision arthroplasty. Clin Orthop Relat Res 170 (1982) 76-82
65. Zimmerli W., and Ochsner P.E. Management of infection associated with prosthetic joints. Infection 31 (2003) 99-108
66. Langlais F. Can we improve the results of revision arthroplasty for infected total hip replacement?. J Bone Joint Surg Br 85 (2003) 637-640
67. Bengston S., Knutson K., and Lidgren L. Treatment of infected knee arthroplasty. Clin Orthop Relat Res 245 (1989) 173-178
68. Rand J.A., Bryan R.S., and Chao E.Y. Failed total knee arthroplasty treated by arthrodesis of the knee using the Ace-Fischer apparatus. J Bone Joint Surg Am 69 (1987) 39-45
69. Segreti J., Nelson J.A., and Trenholme G.M. Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. Clin Infect Dis 27 (1998) 711-713
70. Esposito S., Noviello S., Leone S., Tice A., Seibold G., Nathwani D., et al. Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison. Int J Antimicrob Agents 24 (2004) 473-478
71. Mangram A.J., Horan T.C., Pearson M.L., Silver L.C., and Jarvis W.R. Guideline for prevention of surgical site infection 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 20 (1999) 250-278
72. Bratzler D.W., Houck P.M., and Surgical Infection Prevention Guidelines Writers Workgroup. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 38 (2004) 1706-1715
73. Giannoudis P.V., Parker J., Wilcox M.H., and Methicillin-resistant. Staphylococcus aureus in trauma and orthopaedic practice. J Bone Joint Surg Br 87 (2005) 749-754
74. de Lalla F. Antibiotic prophylaxis in orthopedic prosthetic surgery. J Chemother 1 (2001) 48-53